Wafra Inc’s Quest Diagnostics DGX Stock Holding History

Wafra Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-244,712	Closed	-$19.6M	–	67
2020 Q1	$19.6M	Buy	+244,712	New	+$25.3M	1.5%	31

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wafra Inc's DGX Position: Q2 2020 in Review

Wafra Inc sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 244,712 shares — an estimated $19.6M sold.

Wafra Inc first reported a position in DGX in Q1 2020 and held it in 1 quarter. The position peaked at $19.6M in Q1 2020. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

Wafra Inc reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
Wafra Inc sold 244,712 Quest Diagnostics shares in Q2 2020, an estimated $19.6M.
Wafra Inc first reported a position in Quest Diagnostics in Q1 2020 and held it in 1 quarter.
Wafra Inc's Quest Diagnostics position peaked at $19.6M in Q1 2020.
749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Wafra Inc's 13F filing for Q2 2020, filed 4 Aug 2020.